The Line Plastic Surgery Designated as Advanced Regenerative Medicine Institution by the Ministry of Health and Welfare
The Line Plastic Surgery has been designated as an Advanced Regenerative Medicine Institution by the Ministry of Health and Welfare, effective August 21, 2026. (Designation No. 재생-1-0141)
Through this designation, The Line Plastic Surgery is now authorized to conduct clinical research using stem cells under the Advanced Regenerative Bio Act.
The Line Plastic Surgery has continued research on fat and stem cells since 2007, and was recognized as a Dedicated R&D Department by the Ministry of Science and ICT in 2023. Through this designation, the clinic plans to further develop its accumulated research on SVF (Stromal Vascular Fraction) within a formal clinical research framework.
To learn more about The Line Plastic Surgery's stem cell research, please visit [SVF Lab].
